报价延迟最少15分钟:2026/05/30 23:54 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.04 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1,177.89/--
|
|
企业价值
4.62M
|
| 资产负债 |
|
每股账面净值
-1.48
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets. |
